Pentwater Capital Management LP Pulmonx Corp Transaction History

Pentwater Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$29.72 - $45.1 $745,972 - $1.13 Million	-25,100 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$35.98 - $44.48 $543,298 - $671,648	15,100 Added 151.0%	25,100 $903,000
Q2 2021 Aug 16, 2021	SELL	$37.61 - $48.0 $261,389 - $333,600	-6,950 Reduced 41.0%	10,000 $441,000
Q1 2021 May 17, 2021	BUY	$44.0 - $67.54 $745,800 - $1.14 Million	16,950 New	16,950 $775,000

123

31M

300

204K

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $236M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

Get notified when there are updates to the investment portfolio of Pentwater Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Pentwater Capital Management LP with notifications on news.